- Advertisement -

New Report Charts a Course for Heritable Human Genome Editing

A blue-ribbon commission convened by the National Academy of Sciences (NAS) and the UK’s Royal Society has released a much-anticipated 200-page report on Heritable...

UVA researcher receives $3.4 million grant to improve weight-management programs

A University of Virginia School of Medicine researcher has received $3.4 million from the National Institutes of Health to increase the availability of weight-management...

ASCO: HER2-targeted antibody drug conjugate shows strong anti-tumor activity and durable responses across multiple tumor types

In a new study of trastuzumab deruxtecan, a HER2-targeted antibody drug conjugate, researchers observed encouraging responses and long-lasting clinical benefit in several tumor types....

Mitral Valve Prolapse Caused by Cilia Defects

Mitral valve prolapse (MVP) is a common congenital abnormality of the heart that can cause severe complications such as arrhythmias, heart failure, and sudden cardiac...

Covid-19, cancer and agricultural biotechnology focus BioHabana 2022 – Prensa Latina

Chronic inflammation and aging, brain diseases, industry 4.0, medical technology, bioprocesses and new business models for high-tech sectors are also part of the...

Both cats and dogs often enjoy playing fetch with their owners

Although more common in dogs, 4 in 10 pet cats also choose to play fetch with their owners, Mikel Delgado from Purdue University, US,...

Single-Use Comes of Age—What’s Next?

For much of the past two decades, the biopharmaceutical industry has assessed single-use technologies in terms of adoption: When would they replace stainless steel?...

StockWatch: Revolution Shares Stay Flat Despite Historic FDA Approval of Oral...

Revolution Medicines (Nasdaq: RVMD) appeared to have the makings of another strong stock surge this past week when the FDA approved the company’s historic...

Single-Use Comes of Age—What’s Next?

For much of the past two decades, the biopharmaceutical industry has assessed single-use technologies in terms of adoption: When would they replace stainless steel?...

StockWatch: Revolution Shares Stay Flat Despite Historic FDA Approval of Oral Pancreatic Cancer Therapy

Revolution Medicines (Nasdaq: RVMD) appeared to have the makings of another strong stock surge this past week when the FDA approved the company’s historic...

From Images to Data

Read NowQuantitative spatial biology is coming of age. The desire to learn beyond the surface has always been present but now the ability to...

more new items

Single-Use Comes of Age—What’s Next?

For much of the past two decades, the biopharmaceutical industry has assessed single-use technologies in terms of adoption: When would they replace stainless steel?...

StockWatch: Revolution Shares Stay Flat Despite Historic FDA Approval of Oral...

Revolution Medicines (Nasdaq: RVMD) appeared to have the makings of another strong stock surge this past week when the FDA approved the company’s historic...

From Images to Data

Read NowQuantitative spatial biology is coming of age. The desire to learn beyond the surface has always been present but now the ability to...